Alzheimer's disease

Keywords

Medicine, Disease, Dementia, Epidemiology, Presentation (obstetrics)

References

• Neuroleptic drugs in dementia: benefits and harmR. Mehrotra, David Krause — 2006
• Pathology of familial Alzheimer's disease with Lewy bodies.Tamás Révész, J. L. McLaughlin, Martin N. Rossor — 1997
• Uber eine eigenartige Erkrankung der HirnrindeA. Alzheimer — 1907
• Preclinical trials in autosomal dominant AD: Implementation of the DIAN-TU trialSusan Mills, J. Mallmann, Anna Santacruz — 2013
• A Critique of the Drug Discovery and Phase 3 Clinical Programs Targeting the Amyloid Hypothesis for Alzheimer DiseaseEric Karran, John Hardy — 2014
• Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses.Robert Howard, Rupert McShane, James Lindesay — 2015
• Review: An update on clinical, genetic and pathological aspects of frontotemporal lobar degenerationsTammaryn Lashley, Jonathan D. Rohrer, Simon Mead — 2015
• Meta-analysis of modifiable risk factors for Alzheimer's diseaseWei Xu, Lan Tan, Hui-Fu Wang — 2015
• Dementia in Western Europe: epidemiological evidence and implications for policy makingLois Beech — 2015
• Phases of Aβ-deposition in the human brain and its relevance for the development of ADDietmar Rudolf Thal, Udo Rüb, M Orantes — 2002
• Early Aβ accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brainMartin Ingelsson, Hiroaki Fukumoto, Kathy L. Newell — 2004
• Alzheimer's disease risk genes and mechanisms of disease pathogenesisCeleste M. Karch, Alison Goate — 2014
• Alzheimer's disease and other neurological disordersVictor W. Henderson — 2007
• Correlating familial Alzheimer's disease gene mutations with clinical phenotypeNatalie S. Ryan, Martin N. Rossor — 2010
• Cholinesterase Inhibitors in Alzheimer's DiseaseKenneth L. Davis — 1994
• Self-propagation of pathogenic protein aggregates in neurodegenerative diseasesMathias Jucker, Lary C. Walker — 2013
• The clinical use of structural MRI in Alzheimer diseaseGiovanni B. Frisoni, Nick C. Fox, Clifford R. Jack — 2010
• Neuropathological stageing of Alzheimer-related changesHeiko Braak, Eva Braak — 2004
• Roles of Apolipoprotein E in Alzheimer’s Disease and Other Neurological DisordersPhilip B. Verghese, Joseph M. Castellano, David M. Holtzman — 2011
• EFNS‐ENS/EAN Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's diseaseR. Schmidt, Edith Hofer, Femke H. Bouwman — 2015

Cited by

• Umbilical Cord Mesenchymal Stem Cells Conditioned Medium Promotes Aβ25-35 phagocytosis by Modulating Autophagy and Aβ-Degrading Enzymes in BV2 CellsZhihao Xu, Wenbin Nan, Xiaoyue Zhang — 2018
• Role of epigenetics in Alzheimer's disease pathogenesis.Andrea Stoccoro, Fabio Coppedè — 2018
• Resveratrol Induces Brain Resilience Against Alzheimer Neurodegeneration Through Proteostasis EnhancementRubén Corpas, Christian Griñán‐Ferré, Eduard Rodrı́guez-Farré — 2018
• Immunotherapy to improve cognition and reduce pathological species in an Alzheimer’s disease mouse modelKrystal Herline, Frances Prelli, Pankaj Mehta — 2018
• Mutations of Histidine 13 to Arginine and Arginine 5 to Glycine Are Responsible for Different Coordination Sites of Zinc(II) to Human and Murine Peptides.Bruno Aliès, Valentina Borghesani, Sabrina Noël — 2018
• Recent advancements toward therapeutic vaccines against Alzheimer’s diseaseKrystal Herline, Eleanor Drummond, Thomas Wısnıewskı — 2018
• A Comparison of Lifestyle Interventions for Alzheimer's Disease Extracted from Clinical Notes and LiteratureXin Zhou, Hongfang Liu, Yanshan Wang — 2018
• Omics-based biomarkers for the early Alzheimer Disease diagnosis and reliable therapeutic targets development.Carmen Peña‐Bautista, Miguel Baquero, Máximo Vento — 2019
• A cross-species approach to disorders affecting brain and behaviourOrrin Devinsky, Jordyn M. Boesch, Sofía Cerdá-González — 2018
• Visual Features in Alzheimer's Disease: From Basic Mechanisms to Clinical OverviewMaría Alejandra Cerquera-Jaramillo, Mauricio O. Nava-Mesa, Rodrigo E. González-Reyes — 2018
• The protective effects of polyphenols on Alzheimer's disease: A systematic reviewChiara Colizzi — 2018
• Liraglutide and a lipidized analog of prolactin‐releasing peptide show neuroprotective effects in a mouse model of &bgr;‐amyloid pathologyMartina Holubová, Lucie Hrubá, Andrea Popelová — 2019
• MicroRNA‐128 knockout inhibits the development of Alzheimer's disease by targeting PPAR&ggr; in mouse modelsYanqiu Liu, Yuzheng Zhang, Ping Liu — 2019
• New approaches for the treatment of Alzheimer's disease.Paul V. Fish, David Steadman, Elliott D. Bayle — 2019
• Rare genetic variation implicated in non-Hispanic white families with Alzheimer diseaseGary W. Beecham, Badri N. Vardarajan, Elizabeth Blue — 2018
• The Challenge to Search for New Nervous System Disease Biomarker Candidates: the Opportunity to Use the Proteogenomics ApproachThais Guimarães Martins Nery, Esdras Matheus Gomes da Silva, Raphael Tavares — 2018
• Expansion of the scaffold diversity for the development of highly selective butyrylcholinesterase (BChE) inhibitors: Discovery of new hits through the pharmacophore model generation, virtual screening and molecular dynamics simulation.Xin Lü, Hongyu Yang, Qihang Li — 2019
• Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer’s disease –conformist, nonconformist, and realistic prospects for AD pathogenesisHongmei Li, Chia‐Chen Liu, Hui Zheng — 2018
• Sitagliptin protects the cognition function of the Alzheimer's disease mice through activating glucagon-like peptide-1 and BDNF-TrkB signalings.Qing Dong, Shuai-Wen Teng, Yue Wang — 2019
• Novel, non-nitrocatechol COMT inhibitors modulate dopamine neurotransmission in the frontal cortex and improve cognitive flexibilitySpencer Byers, Ingrid P. Buchler, Michael DePasquale — 2019

Related papers

• Discussion on pathogenesis levels of hypertensionQingguo Wang — 2007
• EXCELLENT ELEMENTS OF PRESENTATION IN BUSINESS ARENAD M Chandravadiya — 2023
• [The incidence of reversible dementia in 145 patients referred on suspicion of dementia].Pia Würtzen Norup, Jan W. Kufahl, Jens Bülow Feilberg — 2002
• When Memory Fails: Helping the Alzheimer's and Dementia PatientA. J. Edwards — 1994
• Exploration on relationship of basic pathogenesis and disease symptomYuanyuan Zhang — 2010
• Analysis of Pathogenesis and Correlative Factors of Acute Upper Gastrointestinal HemorrhageJifu Qu — 2013